Philip Bowden Mitchell
Impact in
- Biological Psychiatry top 0.02%
- Tryptophan and brain disorders
- Psychiatry and Mental health top 0.01%
- Bipolar Disorder and Treatment
- Schizophrenia research and treatment
Papers in
-
- Bipolar Disorder and Treatment 179
- Schizophrenia research and treatment 51
- Electroconvulsive Therapy Studies 39
- Pharmacology 84
- Treatment of Major Depression 78
- Co-authors
- Gordon Barraclough Parker (117 shared papers)Kay A Wilhelm (110 shared papers)Marie‐Paule Austin (43 shared papers)Colleen K A Loo (61 shared papers)Gin S. Malhi (59 shared papers)Adam John Guastella (8 shared papers)Perminder Singh Sachdev (32 shared papers)Ian Bernard Hickie (60 shared papers)
- Journals
- Australian & New Zealand Journal of Psychiatry (67 papers)Journal of Affective Disorders (58 papers)Psychological Medicine (32 papers)The Medical Journal of Australia (24 papers)The Lancet (24 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Philip Bowden Mitchell
700 papers receiving 100.5k citations
Philip Bowden Mitchell's Hit Papers
Peers
Comparison fields: 5 of 231
- Biological Psychiatry 3.4k
- Psychiatry and Mental health 17.9k
- Pharmacology 9.4k
- Neurology 4.3k
- Behavioral Neuroscience 1.7k
Countries citing papers authored by Philip Bowden Mitchell
This map shows the geographic impact of Philip Bowden Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Bowden Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Bowden Mitchell more than expected).
Fields of papers citing papers by Philip Bowden Mitchell
This network shows the impact of papers produced by Philip Bowden Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Bowden Mitchell. The network helps show where Philip Bowden Mitchell may publish in the future.
Co-authors
The 25 scholars most cited alongside Philip Bowden Mitchell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 722 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 Hit paper breakdown → | 2017 | 10887 |
| 2 | Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 Hit paper breakdown → | 2018 | 10763 |
| 3 | Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Hit paper breakdown → | 2012 | 7189 |
| 4 | Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Hit paper breakdown → | 2012 | 6758 |
| 5 | Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 Hit paper breakdown → | 2016 | 5865 |
| 6 | Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 Hit paper breakdown → | 2015 | 5317 |
| 7 | Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 2923 |
| 8 | An international classification and grading system for age-related maculopathy and age-related macular degeneration Hit paper breakdown → | 1995 | 1714 |
| 9 | Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 Hit paper breakdown → | 2017 | 1710 |
| 10 | Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1647 |
| 11 | Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1622 |
| 12 | Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition Hit paper breakdown → | 2015 | 1615 |
| 13 | Analysis of shared heritability in common disorders of the brain Hit paper breakdown → | 2018 | 1441 |
| 14 | Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4 Hit paper breakdown → | 2011 | 1099 |
| 15 | Genome-wide association study identifies 30 loci associated with bipolar disorder Hit paper breakdown → | 2019 | 1065 |
| 16 | Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders Hit paper breakdown → | 2019 | 965 |
| 17 | Cognitive deficits in depression: Possible implications for functional neuropathology Hit paper breakdown → | 2001 | 962 |
| 18 | Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology Hit paper breakdown → | 2021 | 938 |
| 19 | Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression Hit paper breakdown → | 2003 | 684 |
| 20 | Oxytocin Increases Gaze to the Eye Region of Human Faces Hit paper breakdown → | 2007 | 653 |
About Philip Bowden Mitchell
Philip Bowden Mitchell is a scholar working on Psychiatry and Mental health, Pharmacology, Clinical Psychology, Neurology and Genetics, having authored 722 papers that have together received 104.1k indexed citations. Recurring topics across this work include Bipolar Disorder and Treatment (179 papers), Treatment of Major Depression (78 papers), Schizophrenia research and treatment (51 papers), Genetic Associations and Epidemiology (51 papers), Electroconvulsive Therapy Studies (39 papers), Transcranial Magnetic Stimulation Studies (37 papers), Functional Brain Connectivity Studies (34 papers) and Genetics and Neurodevelopmental Disorders (34 papers). The work is most often cited by research in Biological Psychiatry (3.4k citations), Psychiatry and Mental health (17.9k citations), Pharmacology (9.4k citations), Neurology (4.3k citations) and Behavioral Neuroscience (1.7k citations). Philip Bowden Mitchell has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Gordon Barraclough Parker, Kay A Wilhelm, Marie‐Paule Austin, Colleen K A Loo, Gin S. Malhi, Adam John Guastella, Perminder Singh Sachdev, Ian Bernard Hickie, Guy M. Goodwin and Mark R. Dadds. Their work appears in journals such as Australian & New Zealand Journal of Psychiatry, Journal of Affective Disorders, Psychological Medicine, The Medical Journal of Australia and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.